Phospholipase C beta 1 Antikörper (AA 781-896)

Produktnummer ABIN7142041

Produktdetails anti-Phospholipase C beta 1 Antikörper

Target: Phospholipase C beta 1 (PLCB1) (phospholipase C, beta 1 (phosphoinositide-Specific) (PLCB1))

Bindungsspezifität: AA 781-896

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Phospholipase C beta 1 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 protein (781-896AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu Phospholipase C beta 1

Target: Phospholipase C beta 1 (PLCB1) (phospholipase C, beta 1 (phosphoinositide-Specific) (PLCB1))

Andere Bezeichnung: PLCB1 (PLCB1 Produkte)

Synonyme: PLCB1 antikoerper, 3110043I21Rik antikoerper, AI132408 antikoerper, Plcb antikoerper, mKIAA0581 antikoerper, EIEE12 antikoerper, PI-PLC antikoerper, PLC-154 antikoerper, PLC-I antikoerper, PLC154 antikoerper, PLCB1A antikoerper, PLCB1B antikoerper, PLC'1 antikoerper, PLCbeta1 antikoerper, Phosphb antikoerper, RATPHOSPHB antikoerper, phospholipase C beta 1 antikoerper, phospholipase C beta 1 S homeolog antikoerper, phospholipase C, beta 1 antikoerper, PLCB1 antikoerper, plcb1.S antikoerper, Plcb1 antikoerper

Hintergrund:

Background: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes.

Aliases: 1 phosphatidylinositol 4,5 bisphosphate phosphodiesterase beta 1 antibody, 1-phosphatidyl-D-myo-inositol-4,5-bisphosphate antibody, 1-phosphatidylinositol 4 antibody, 1-phosphatidylinositol-4 antibody, 5-bisphosphate phosphodiesterase beta-1 antibody, EIEE12 antibody, Inositoltrisphosphohydrolase antibody, Monophosphatidylinositol phosphodiesterase antibody, Phosphb antibody, Phosphoinositidase C antibody, Phosphoinositide phospholipase C antibody, Phosphoinositide phospholipase C-beta 1 antibody, Phosphoinositide phospholipase C-beta-1 antibody, Phospholipase C beta 1 (phosphoinositide-specific) antibody, Phospholipase C I antibody, Phospholipase C-beta-1 antibody, Phospholipase C-I antibody, PI PLC antibody, PLC 1 antibody, PLC beta 1 antibody, PLC I antibody, PLC-154 antibody, PLC-beta-1 antibody, PLC-I antibody, PLC154 antibody, Plcb antibody, Plcb1 antibody, Plcb1 protein antibody, PLCB1_HUMAN antibody, PLCbeta1 antibody, Triphosphoinositide phosphodiesterase antibody

UniProt: Q9NQ66

Pathways: WNT Signalweg, AMPK Signaling, Thyroid Hormone Synthesis, Inositol Metabolic Process, Regulation of Muscle Cell Differentiation, Regulation of G-Protein Coupled Receptor Protein Signaling, Proton Transport, Skeletal Muscle Fiber Development, CXCR4-mediated Signaling Events, G-protein mediated Events